VAERS Explorer
Back to explore

Report #2859478

Received Sep 17, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
—
Recovered
Recovered
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
UNKVACCINE NOT SPECIFIED (NO BRAND NAME)UNKNOWN MANUFACTURERUNK—IM

Symptoms (1)

Pain in extremity

Symptom narrative

my side effects were minimal (sore arm)/ I only had a sore arm/it definitely gave me only one side effect of a sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (my side effects were minimal (sore arm)/ I only had a sore arm/it definitely gave me only one side effect of a sore arm) in a patient of an unknown age and gender who received mRNA-1283 (MNEXSPIKE PFS) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1283 (MNEXSPIKE PFS) (Intramuscular use) .2 milliliter. On an unknown date, the patient experienced PAIN IN EXTREMITY (my side effects were minimal (sore arm)/ I only had a sore arm/it definitely gave me only one side effect of a sore arm). At the time of the report, PAIN IN EXTREMITY (my side effects were minimal (sore arm)/ I only had a sore arm/it definitely gave me only one side effect of a sore arm) had resolved. Concomitant medication was not provided. It was reported that the patient had been happy to receive the vaccine as minimal side effects had been experienced. It was unknown if the patient experienced any additional symptoms or events. Treatment medication was not reported. This case was linked to US-MODERNATX, INC.-MOD-2025-789277 (E2B Linked Report). This case was linked to MOD-2025-789285 (Patient Link).; Sender's Comments: US-MODERNATX, INC.-MOD-2025-789277:Patient 2